Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TRDA |
---|---|---|
09:32 ET | 2361 | 17.61 |
09:35 ET | 1310 | 17.48 |
09:37 ET | 100 | 17.44 |
09:39 ET | 1361 | 17.56 |
09:42 ET | 100 | 17.59 |
09:44 ET | 100 | 17.61 |
09:46 ET | 200 | 17.73 |
09:51 ET | 100 | 17.72 |
09:55 ET | 543 | 17.69 |
10:00 ET | 200 | 17.71 |
10:02 ET | 100 | 17.84 |
10:06 ET | 200 | 17.76 |
10:08 ET | 100 | 17.8 |
10:09 ET | 400 | 17.85 |
10:11 ET | 100 | 17.905 |
10:13 ET | 100 | 17.905 |
10:22 ET | 300 | 17.81 |
10:26 ET | 100 | 17.895 |
10:27 ET | 400 | 17.9 |
10:40 ET | 400 | 17.985 |
10:45 ET | 500 | 18.1 |
10:47 ET | 1394 | 18 |
10:54 ET | 1802 | 18.04 |
10:56 ET | 200 | 18.01 |
11:09 ET | 200 | 17.95 |
11:12 ET | 776 | 17.96 |
11:14 ET | 300 | 17.975 |
11:18 ET | 100 | 17.99 |
11:20 ET | 115 | 17.9156 |
11:23 ET | 100 | 17.97 |
11:30 ET | 100 | 17.9 |
11:34 ET | 548 | 17.89 |
11:36 ET | 10007 | 17.9 |
11:38 ET | 4403 | 17.84 |
11:39 ET | 4711 | 17.735 |
11:41 ET | 3904 | 17.79 |
11:43 ET | 1100 | 17.77 |
11:45 ET | 2200 | 17.7 |
11:56 ET | 100 | 17.7 |
11:57 ET | 300 | 17.62 |
12:01 ET | 624 | 17.64 |
12:06 ET | 100 | 17.64 |
12:12 ET | 1999 | 17.595 |
12:14 ET | 200 | 17.6 |
12:24 ET | 3246 | 17.635 |
12:39 ET | 295 | 17.7005 |
12:42 ET | 100 | 17.705 |
12:44 ET | 100 | 17.7 |
12:46 ET | 300 | 17.69 |
12:48 ET | 100 | 17.65 |
01:08 ET | 100 | 17.6 |
01:09 ET | 700 | 17.6 |
01:15 ET | 100 | 17.615 |
01:24 ET | 200 | 17.6 |
01:26 ET | 1000 | 17.62 |
01:27 ET | 100 | 17.62 |
01:29 ET | 400 | 17.62 |
01:31 ET | 200 | 17.625 |
01:33 ET | 498 | 17.63 |
01:36 ET | 100 | 17.63 |
01:38 ET | 475 | 17.63 |
01:40 ET | 1450 | 17.7 |
01:42 ET | 100 | 17.71 |
01:44 ET | 417 | 17.69 |
01:49 ET | 400 | 17.705 |
01:51 ET | 200 | 17.705 |
01:54 ET | 100 | 17.705 |
01:58 ET | 378 | 17.705 |
02:00 ET | 100 | 17.705 |
02:02 ET | 100 | 17.705 |
02:18 ET | 597 | 17.71 |
02:20 ET | 500 | 17.735 |
02:30 ET | 200 | 17.705 |
02:32 ET | 100 | 17.705 |
02:34 ET | 1300 | 17.76 |
02:36 ET | 100 | 17.76 |
02:41 ET | 600 | 17.67 |
02:43 ET | 1325 | 17.67 |
02:45 ET | 397 | 17.715 |
02:52 ET | 100 | 17.7 |
03:01 ET | 497 | 17.7 |
03:06 ET | 100 | 17.715 |
03:12 ET | 200 | 17.725 |
03:15 ET | 136 | 17.725 |
03:17 ET | 100 | 17.725 |
03:19 ET | 1428 | 17.8199 |
03:21 ET | 200 | 17.75 |
03:24 ET | 5333 | 17.75 |
03:28 ET | 134 | 17.76 |
03:30 ET | 4854 | 17.765 |
03:32 ET | 200 | 17.75 |
03:35 ET | 100 | 17.76 |
03:37 ET | 8782 | 17.72 |
03:39 ET | 148 | 17.73 |
03:42 ET | 471 | 17.75 |
03:44 ET | 500 | 17.825 |
03:48 ET | 100 | 17.82 |
03:51 ET | 1050 | 17.825 |
03:53 ET | 300 | 17.83 |
03:55 ET | 400 | 17.8 |
03:57 ET | 100 | 17.76 |
04:00 ET | 15353 | 17.77 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Entrada Therapeutics Inc | 654.7M | 6.0x | --- |
Avid Bioservices Inc | 655.2M | -4.6x | --- |
Y-mAbs Therapeutics Inc | 657.0M | -26.5x | --- |
Alector Inc | 488.6M | -2.9x | --- |
Adaptive Biotechnologies Corp | 783.1M | -3.6x | --- |
Kamada Ltd | 340.4M | 20.3x | -22.48% |
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a class of medicines, which engages intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform (EEV Platform), the Company is building a robust development portfolio of therapeutic candidates. Its first two drug candidates, ENTR-601-44 and VX-670, are in clinical trials. VX-670 for dystrophy type 1 (DM1) is designed to block the triplet repeats in the messenger RNA (mRNA). ENTR-601-44 is in a Phase I clinical trial. The Company also announced the selection of additional clinical candidates within its Duchenne franchise, ENTR-601-45 and ENTR-601-50.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $654.7M |
---|---|
Revenue (TTM) | $239.4M |
Shares Outstanding | 37.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $2.96 |
Book Value | $7.25 |
P/E Ratio | 6.0x |
Price/Sales (TTM) | 2.7 |
Price/Cash Flow (TTM) | 6.1x |
Operating Margin | 39.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.